For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $18.24 down -6.37% from the previous closing price of $19.48. In other words, the price has decreased by -$6.37 from its previous closing price. On the day, 6.09 million shares were traded. ALHC stock price reached its highest trading level at $18.525 during the session, while it also had its lowest trading level at $15.9.
Ratios:
For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 3.39 whereas as Long-Term Debt/Eq ratio is at 3.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 14 ’25 when Maroney Dawn Christine sold 230,000 shares for $19.10 per share. The transaction valued at 4,392,195 led to the insider holds 2,132,899 shares of the business.
KAO JOHN E sold 90,000 shares of ALHC for $1,718,721 on Apr 14 ’25. The Chief Executive Officer now owns 2,003,100 shares after completing the transaction at $19.10 per share. On Apr 14 ’25, another insider, JEK TRUST U/A DTD 02/08/2021, who serves as the Director of the company, bought 270,000 shares for $19.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3499015680 and an Enterprise Value of 3359950848. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.29 while its Price-to-Book (P/B) ratio in mrq is 35.03. Its current Enterprise Value per Revenue stands at 1.243 whereas that against EBITDA is -47.05.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.25, which has changed by 2.6407185 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 11.73%, while the 200-Day Moving Average is calculated to be 46.88%.
Shares Statistics:
Over the past 3-months, ALHC traded about 2.60M shares per day on average, while over the past 10 days, ALHC traded about 4370070 shares per day. A total of 191.78M shares are outstanding, with a floating share count of 106.41M. Insiders hold about 44.53% of the company’s shares, while institutions hold 56.75% stake in the company. Shares short for ALHC as of 1743379200 were 9501930 with a Short Ratio of 3.65, compared to 1740700800 on 7050837. Therefore, it implies a Short% of Shares Outstanding of 9501930 and a Short% of Float of 7.7299999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
